I run a memory care facility in Michigan and serve as CFO and medical director across multiple care settings, so I'm seeing 2026 Medicaid changes hit from both the clinical and finance sides. Michigan's MI Choice Waiver already doesn't cover room and board for memory care--families pay $9,500-9,900 monthly out of pocket while the waiver theoretically covers services. When redetermination frequencies increase in 2026, we're going to lose residents mid-stay because families can't steer the paperwork fast enough, and someone with advanced dementia can't advocate for themselves. The real crisis nobody's quantifying is what happens when visiting physicians stop taking Medicaid. I run Responsive Visiting Physicians, and our reimbursement for a dementia patient home visit is $92 while the actual cost with drive time and documentation is $240. We're absorbing the loss now, but if proposed cuts go through, facilities like Memory Lane won't have doctors willing to come on-site. That means ambulance transfers to ERs for things we could handle in-house--I work ER shifts and I'm already seeing dementia patients arriving by EMS for medication adjustments that a visiting doc could've managed for $92 instead of a $3,400 ER bill that Medicaid pays anyway. Hospice reimbursement cuts will force memory care residents to die in hospitals instead of peacefully at home. I'm medical director for Open Arms Hospice, and Medicaid pays us $198 per day for end-of-life dementia care that requires round-the-clock nursing. Private insurance pays $325. Our agency serves 12 memory care facilities now, but if rates drop another 8-10% as projected, we'll have to stop serving Medicaid patients in buildings more than 15 minutes away because the travel costs don't pencil. A 78-year-old with late-stage Alzheimer's will spend their final week in a hospital room under fluorescent lights instead of in the memory care home they've known for three years.
As 2026 approaches, several Medicaid policy shifts are poised to reshape coverage and access, particularly for low-income families, non-citizens, and individuals relying on behavioral health services. One of the most notable changes will be tighter eligibility oversight and frequent redeterminations, a continuation of the post-pandemic unwinding. This means more beneficiaries may experience a loss, failing coverage not due to ineligibility but to paperwork barriers or administrative errors. Some states are expected to revisit coverage for certain non-citizen groups, potentially widening access gaps further. With federal matching funds shrinking and financial responsibility shifting to states, we're likely to see pressures on Medicaid budgets that translate into narrower provider networks and reduced reimbursement rates. When states tighten spending, provider participation drops, especially among specialists, and rural communities, already stretched thin, may face the greatest impact. Even modest reimbursement reductions can destabilize rural hospitals, which rely on Medicaid volume; at the same time, urban hospitals serving safety-net populations may face cuts that deepen existing financial strain. Behavioral health systems are helpless. Since Medicaid is the primary payer for substance-use treatment and community mental-health services, any reduction in funding or administrative flexibility risks shrinking treatment capacity, mainly in rural and underserved regions. Policymakers often underestimate how administrative hurdles to eligibility rules can disrupt care. For beneficiaries, the most important advice heading into 2026 is to stay proactive with renewals and understand state-specific changes early. Medicaid's structure is resilient, but the coming year will test its ability to protect access amid fiscal and political pressures.
I can answer many of your questions, especially about Medi-Cal changes in California. But not from a public health perspective. I focus exclusively on California and major changes to Medi-Cal are coming in 2026. But I can't help nationwide coverage, or even talk about access to healthcare and data.
Founder & Medical Director at New York Cosmetic Skin & Laser Surgery Center
Answered 4 months ago
As a dermatologist in New York, I am not a Medicaid policy architect, but I live with outcomes. I see what happens when a patient loses coverage after a confusing renewal. Biologic drugs for psoriasis or eczema vanish. People skip skin cancer checks. When hospitals that rely on Medicaid cut staff or specialty clinics, my patients feel it as long waits and emergency visits. For 2026, I worry that tighter eligibility rules and faster redeterminations will worsen this churn, especially if states carry more financial risk. That strain often becomes lower reimbursement and fewer specialists willing to see Medicaid patients. Cuts to behavioral health show up on the skin as picking, rashes, and slow healing after surgery. Recent 2025 Medicaid data show rising spending pressure even as enrollment drops: https://www.kff.org/medicaid/medicaid-enrollment-spending-growth-fy-2025-2026/
1. Expected Medicaid policy changes in 2026 "Republican policy direction — reinforced by Trump's agenda — is shifting Medicaid toward greater state control, more frequent eligibility checks, and stricter rules for non-citizens. The 2025-2026 budget already includes measures that allow states to increase redetermination frequency for adults with unstable income and limit federal support for Emergency Medicaid and children's coverage for non-citizens. These changes will likely produce higher administrative drop-offs and narrower eligibility." 2. How shifting financial responsibility to states may impact services and access "The reduction of federal matching funds in the current budget means states will face higher Medicaid costs. Most will respond by cutting optional benefits, reducing reimbursement rates, or tightening enrollment systems. Lower reimbursement almost always leads to fewer providers accepting Medicaid, increasing wait times and reducing access, especially in urban and rural areas that already operate at the edge of financial sustainability." 3. Impact of provider taxes, assessments, and reimbursement changes on hospitals "New federal limits on provider taxes and hospital assessments directly affect safety-net systems. Large urban hospitals warn that the 2025-2026 rules could destabilize budgets that rely heavily on Medicaid and DSH payments. Rural hospitals are even more vulnerable: reduced reimbursement can force closures of behavioral health units or maternity wards, cutting off essential services for entire regions." 4. Effects on behavioral health and substance-use treatment "Because Medicaid is the primary payer for behavioral health and substance-use treatment, any reduction in state resources immediately affects capacity. Treatment centers in rural areas are especially at risk. If states cut rates or restrict eligibility, we will see fewer providers, longer waitlists, and more patients falling out of continuous care." 5. Downstream effects on vulnerable populations and continuity of care "The biggest risk is disruption of ongoing treatment. More frequent eligibility checks combined with lower provider participation will lead to gaps in medication access and cancelled appointments. Vulnerable populations with chronic illnesses, mental-health conditions, or substance-use disorders will experience the sharpest decline in continuity of care."
As a physician who cares for many Medicaid patients, I'm closely watching how the anticipated Medicaid policy changes in 2026 could affect eligibility, renewals, and access to care, especially for vulnerable populations. Based on what I'm seeing in practice and hearing from hospital leaders, more frequent redeterminations and tighter eligibility rules risk pushing people off coverage simply due to paperwork barriers, not because they no longer qualify. I've already had patients lose insurance temporarily after pandemic-era protections ended, leading to missed medications, delayed procedures, and avoidable ER visits. Shifting more financial burden to states will likely translate into tighter reimbursement, which directly affects whether specialists, rural clinics, and hospital systems can continue serving high-need communities. Changes to provider taxes and reimbursement structures may stabilize state budgets on paper, but in reality they threaten already-strained urban and rural hospitals that depend heavily on Medicaid revenue. In my own region, I've seen behavioral health referrals delayed for months because Medicaid-funded treatment capacity is already thin, and further cuts could make those gaps dangerous. Since Medicaid is the primary payer for substance-use and mental health treatment, reimbursement pressures almost always lead to fewer beds, fewer providers, and longer waits—especially outside major cities. The downstream effect is predictable: interrupted care, worsening chronic disease, and higher long-term costs that ultimately land back on emergency systems and taxpayers.
At A-S Medication Solutions, we are not policy architects, but working within pharmacy distribution and reimbursement gives us a close view of how Medicaid shifts ripple through access and continuity of care. The biggest concern heading into 2026 is the tightening around eligibility and more frequent redeterminations. Every time beneficiaries fall off the rolls due to paperwork lapses rather than true ineligibility, we see immediate disruptions in medication adherence. Our partners report that refill gaps increase within weeks, especially for chronic conditions where stability depends on uninterrupted coverage. When states shoulder a larger share of financial responsibility, they often respond by narrowing formularies or slowing reimbursement cycles. Those delays quietly push smaller pharmacies and rural providers to step back from Medicaid participation because they cannot absorb the cash-flow strain. We also watch provider taxes and system assessments closely because they shape hospital stability in ways most consumers never see. Urban hospitals already operating on thin margins feel the pressure first. Rural facilities, where Medicaid is often the dominant payer for behavioral health and substance-use treatment, face the risk of reducing capacity simply because reimbursement no longer covers operational cost. The downstream effect is predictable. Vulnerable populations lose consistent touchpoints, relapse rates rise and emergency departments absorb the overflow. Policy debates often focus on budgets, but on the ground, these shifts redefine whether patients can maintain a treatment plan without interruption.
I'd be happy to contribute to your piece on Medicaid changes expected in 2026 and beyond. From my perspective working directly with employers, providers, and patients—and with a spouse who is a practicing physician—I'm able to see these shifts from both the financial/policy side and the clinical front lines. Many programs the public assumes are simply "part of the hospital" or "part of the clinic" are actually heavily funded by government dollars through Medicaid, grants, and supplemental payments. As those funding streams face pressure, organizations often respond quietly and early. You can already see this in clinic and hospital behavior: downsizing staff, closing satellite offices, cutting service lines, and laying off employees to prepare for anticipated reductions. These moves are often framed as efficiency or restructuring, but they are frequently preemptive responses to projected government funding cuts. As more financial burden shifts to states, we're likely to see stricter eligibility enforcement, more frequent redeterminations, and harder decisions about which Medicaid services are prioritized. This can lead to fewer providers accepting Medicaid, longer wait times, and worsening access—especially in rural areas and underserved urban communities. Hospital reimbursement mechanisms, including provider taxes, system assessments, and supplemental payments, play a critical role in stability. When those reimbursements shrink, hospitals often cut "unprofitable" but essential services such as behavioral health, maternity care, and outpatient clinics. We're already seeing signs of this pressure contributing to consolidations, clinic closures, and reduced access points. Behavioral health and substance-use treatment are particularly vulnerable, as Medicaid is the primary payer. Even modest reimbursement or funding changes can result in fewer treatment slots, longer waitlists, and reduced capacity—especially in rural areas where alternatives are limited. When funding tightens, so-called "non-essential" supports like transportation, outreach workers, bilingual navigators, and extended clinic hours are often first on the chopping block. That's where people truly fall through the cracks: missed renewals, lost coverage, unmanaged chronic conditions, and avoidable ER visits. I can help connect the dots between policy decisions, hospital and clinic financial behavior, and what beneficiaries experience in terms of access, coverage, and continuity of care.